Ocean Biomedical, Inc. SEC filings OCEA
Ocean Biomedical, Inc. has 255 filings in SEC EDGAR's recent list, going back to Jul 19, 2021. Its latest annual report, Form 10-K, was filed on Apr 8, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on May 15, 2025, covering the quarter ended Mar 31, 2025. The most recent current report (Form 8-K) was filed on Aug 5, 2025 (listing notice, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 26, 2024 | — |
| 4 | Insider transaction | Oct 6, 2023 | Oct 2, 2023 |
| 4 | Insider transaction | Mar 24, 2023 | Mar 22, 2023 |
| 4/A | Filing | Mar 24, 2023 | Feb 28, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 24, 2023 | — |
| 4 | Insider transaction | Mar 2, 2023 | Feb 28, 2023 |
| 4 | Insider transaction | Mar 2, 2023 | Feb 28, 2023 |
| SC 13D | Ownership over 5% (active) | Feb 24, 2023 | — |
| SC 13D | Ownership over 5% (active) | Feb 24, 2023 | — |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 17, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 17, 2023 | — |
| 4 | Insider transaction | Feb 16, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 16, 2023 | Feb 14, 2023 |
| 4 | Insider transaction | Feb 16, 2023 | Feb 14, 2023 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 31, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 4, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 3, 2022 | — |
| 4 | Insider transaction | Dec 16, 2021 | Nov 3, 2021 |
| 4 | Insider transaction | Dec 16, 2021 | Nov 3, 2021 |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 10, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Sep 27, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Sep 24, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Sep 23, 2021 | — |
| 3 | Initial insider ownership | Sep 21, 2021 | Sep 14, 2021 |
| SC 13G | Ownership over 5% (passive) | Sep 20, 2021 | — |
| 3 | Initial insider ownership | Sep 20, 2021 | Sep 14, 2021 |
| 3 | Initial insider ownership | Sep 20, 2021 | Sep 14, 2021 |
| 3 | Initial insider ownership | Sep 20, 2021 | Sep 14, 2021 |
| 3 | Initial insider ownership | Sep 20, 2021 | Sep 14, 2021 |
| 3 | Initial insider ownership | Sep 20, 2021 | Sep 14, 2021 |
| 3 | Initial insider ownership | Sep 20, 2021 | Sep 14, 2021 |
Showing 73 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OCEA (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1869974
- Former names
- Ocean Biomedical, Inc./DE (until Feb 15, 2023); Aesther Healthcare Acquisition Corp. (until Feb 14, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.